PL3768274T3 - Kompozycje zawierające połączenie kwasu glikocholowego i kwasu masłowego lub kwasu oleinowego do zastosowania w leczeniu osteoporozy - Google Patents

Kompozycje zawierające połączenie kwasu glikocholowego i kwasu masłowego lub kwasu oleinowego do zastosowania w leczeniu osteoporozy

Info

Publication number
PL3768274T3
PL3768274T3 PL19770322.6T PL19770322T PL3768274T3 PL 3768274 T3 PL3768274 T3 PL 3768274T3 PL 19770322 T PL19770322 T PL 19770322T PL 3768274 T3 PL3768274 T3 PL 3768274T3
Authority
PL
Poland
Prior art keywords
acid
butary
osteoporosis
treatment
combination
Prior art date
Application number
PL19770322.6T
Other languages
English (en)
Inventor
Lars Fändriks
Ville Wallenius
Original Assignee
Epicyt Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicyt Pharma Ab filed Critical Epicyt Pharma Ab
Publication of PL3768274T3 publication Critical patent/PL3768274T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19770322.6T 2018-03-19 2019-03-19 Kompozycje zawierające połączenie kwasu glikocholowego i kwasu masłowego lub kwasu oleinowego do zastosowania w leczeniu osteoporozy PL3768274T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1850304 2018-03-19
PCT/SE2019/050246 WO2019182501A1 (en) 2018-03-19 2019-03-19 A composition for use in the treatment of conditions caused by calcium deficiency

Publications (1)

Publication Number Publication Date
PL3768274T3 true PL3768274T3 (pl) 2024-06-17

Family

ID=67987480

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19770322.6T PL3768274T3 (pl) 2018-03-19 2019-03-19 Kompozycje zawierające połączenie kwasu glikocholowego i kwasu masłowego lub kwasu oleinowego do zastosowania w leczeniu osteoporozy

Country Status (11)

Country Link
US (1) US11679124B2 (pl)
EP (1) EP3768274B1 (pl)
JP (1) JP7383626B2 (pl)
CN (1) CN112074274B (pl)
AU (1) AU2019239073B2 (pl)
CA (1) CA3094162A1 (pl)
ES (1) ES2974199T3 (pl)
MX (1) MX2020009629A (pl)
PL (1) PL3768274T3 (pl)
SA (1) SA520420164B1 (pl)
WO (1) WO2019182501A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022173928A (ja) * 2021-05-10 2022-11-22 共栄化学工業株式会社 皮膚外用剤
CN116159068A (zh) * 2021-11-25 2023-05-26 香港理工大学深圳研究院 胆汁酸和/或胆汁酸受体激动剂的新应用
CN115282136B (zh) * 2022-08-09 2023-10-20 中南大学 丁酸钠在制备预防和/或治疗继发性甲状旁腺功能亢进制剂中的应用
NO349080B1 (en) * 2023-04-26 2025-09-15 Epax Norway As Very long chain fatty acids for use in mineralization
CN119269711A (zh) * 2024-09-26 2025-01-07 北京大学第三医院(北京大学第三临床医学院) 一种胆汁酸在预测骨量及其作为骨代谢标志物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
EP0252004A1 (de) * 1986-06-26 1988-01-07 Ciba-Geigy Ag Pharmazeutische Zusammensetzungen für die parenterale Applikation
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
ITMI20011321A1 (it) * 2001-06-22 2002-12-22 Chiesi Farma Spa Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del
US20060052305A1 (en) 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
US20070292493A1 (en) * 2006-06-15 2007-12-20 Brierre Barbara T Pharmaceutical composition and method for the transdermal delivery of calcium
JP5283043B2 (ja) 2007-06-04 2013-09-04 学校法人日本大学 作用選択的ビタミンd受容体作用剤
AP2895A (en) * 2007-12-24 2014-05-31 Sun Pharma Advanced Res Co Ltd Nanodispersion
ES3058497T3 (en) 2008-09-17 2026-03-11 Amryt Endo Inc Pharmaceutical compositions comprising polypeptides and related methods of delivery
US8563053B2 (en) 2009-10-29 2013-10-22 Shaker A. Mousa Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis
WO2011116139A2 (en) * 2010-03-16 2011-09-22 Chiasma Inc. Improved pharmaceutical compositions and methods of delivery
US11154559B2 (en) 2011-09-29 2021-10-26 Ethicon Endo-Surgery, Inc. Methods and compositions of bile acids

Also Published As

Publication number Publication date
EP3768274B1 (en) 2023-11-15
CN112074274A (zh) 2020-12-11
EP3768274C0 (en) 2023-11-15
CN112074274B (zh) 2024-03-26
RU2020133327A (ru) 2022-04-19
US20210000864A1 (en) 2021-01-07
AU2019239073B2 (en) 2024-12-05
JP7383626B2 (ja) 2023-11-20
CA3094162A1 (en) 2019-09-26
SA520420164B1 (ar) 2022-11-08
AU2019239073A1 (en) 2020-11-12
MX2020009629A (es) 2021-01-08
WO2019182501A1 (en) 2019-09-26
EP3768274A4 (en) 2022-01-05
EP3768274A1 (en) 2021-01-27
ES2974199T3 (es) 2024-06-26
JP2021517578A (ja) 2021-07-26
US11679124B2 (en) 2023-06-20
BR112020018980A2 (pt) 2020-12-29

Similar Documents

Publication Publication Date Title
EP3704239A4 (en) CASZ COMPOSITIONS AND METHOD OF USE
SI3600270T1 (sl) Spojine in sestavki za zdravljenje hematoloških motenj
EP3655534C0 (en) COMPOSITIONS AND METHODS FOR TREATING BETA-HEMOGLOBINOPATHIES
PL3500287T3 (pl) Kompozycja zawierająca samoorganizujące się peptydy do stosowania do leczenia zapalenia przyzębia i/lub zapalenia tkanek okołowszczepowych
SI4101454T1 (sl) Sestavki za uporabo pri zdravljenju hipertenzije
PL3634415T3 (pl) Kompozycje okulistyczne zawierające brymonidynę i ketotifen do zastosowania w leczeniu alergii
EP3601460A4 (en) POLISHING COMPOSITIONS AND METHOD FOR THEIR USE
EP3319534C0 (en) SYSTEMS FOR THE TREATMENT AND PREVENTION OF FEMALE PELVIC DYSFUNCTION
PL3810128T3 (pl) Kompozycje do leczenia i/lub zapobiegania chorobom związanym z agregacją białek
SG11202102783QA (en) Pharmaceutical composition in the form of a water-in-oil emulsion (w/o) and its uses
EP3768274C0 (en) COMPOSITION COMPRISING A COMBINATION OF GLYCOCHOLIC ACID AND BUTYRIC ACID OR OLEIC ACID FOR THE TREATMENT OF OSTEOPOROSIS
EP3285789A4 (en) PLANT EXTRACTS FOR THE TREATMENT OF OVERWEIGHT AND ADIPOSITAS
PL3478310T3 (pl) Kompozycje przydatne w zapobieganiu i/lub leczeniu zapalenia i bólu stawów i kości oraz uszkodzenia chrząstki
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
EP3518951C0 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF OSTEOPOROSIS AND BONE FRACTURES
PL3823657T3 (pl) Kompozycje do zastosowań kosmetycznych i dermatologicznych
EP3582817C0 (en) Tissue scaffold and scaffold composition
EP3694391C0 (en) DEVICE FOR USE IN THE TREATMENT OF HEMORRHOIDS
IL280910A (en) Methods and compounds for the treatment of patients exposed to chemical substances
PL4072532T3 (pl) Postać dawkowania do zastosowania w leczeniu lub zapobieganiu chorobie
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
EP3471720C0 (en) FORMULATION FOR USE IN THE TREATMENT OF UREMIC PRURITO
EP4295864B1 (en) Dibenzoazepine compounds intended for use in the treatment of Neisseria and retrovirus infections
EP3761990C0 (en) COMPOSITIONS FOR THE TREATMENT OF FOOT INFECTIONS
PL3654932T3 (pl) Tyrotrycyna do zastosowania w leczeniu lub profilaktyce zapachu ciała oraz preparaty do tego zastosowania